A new UCL-led international trial will assess whether AI can perform as well as expert radiologists at detecting prostate ...

An investigator presented final results from the Optilume BPH trials PINNACLE and EVEREST at the American Urological Association annual meeting.

The AUA 2026 conference featured practice-changing abstracts in the field of urologic oncology. Urologists from Fox Chase ...

In recognition of Men's Health Month in June, the MRH Urology Clinic is highlighting expanded treatment options for enlarged ...

Prostate cancer screening is one of the most common decisions men face in primary care, yet many patients make that choice without fully understanding the potential benefits and harms. A new editorial ...

Hundreds of ovarian cancer patients are set to be offered a new treatment after it was given the green light from the NHS. A ...

Data from the PROTEUS trial showed that adding a hormone-blocking pill called apalutamide to standard hormone therapy, both ...

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...

The foundation asked for $6.4m over four years in Budget 2026 to fund two regional pilots for early detection screening for prostate cancer. MetService is warning of possible flooding and slips, with ...

"Burnham backs state control in blast at Blair" reads the front page headline of the Times. It summarises the Greater Manchester mayor's statement saying "neoliberalism has failed Britain" and quotes ...

Only "a few thousand" men who have a dangerous genetic variant and a family history of cancer should be screened, experts say ...

An oncologist, Kunle Odunsi, has emphasised the need to develop a standard infrastructure for cancer treatment in Nigeria and ensure the availability of quality drugs to tackle the country’s growing ...